YOLFTbeta
06

Ckd Bio

063160 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

11,120.00KRW-480.00 (-4.14%)

Price History

Full chart

Market Stats

Previous Close11,600.00
Open11,530.00
Day Range11,070.00 – 11,600.00
52-Week Range11,770.00 – 24,900.00
Volume8.72K
Market Cap70.11B
P/E (TTM)0.00
Forward P/E14.79
Dividend Yield0.00%
Beta0.61
50-Day Avg13,433.20
200-Day Avg17,304.90

About

CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOWan-Kap Park
  • Employees519
  • Headquarters8 Chungjeong-ro, Seoul, South Korea, 03742, Korea
  • Websitehttps://www.ckdbio.com

Leadership

  • Wan-Kap ParkChief Executive Officer
  • Mr. Hui Yil KangVP & Director

Financials

Income Statement

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue83.39B106.55B121.57B110.53B113.76B100.37B106.39B106.69B113.01B118.19B124.51B137.18B124.60B142.24B156.04B160.35B171.76B160.07B
Growth (%)-+27.77%+14.09%-9.08%+2.92%-11.77%+6.00%+0.28%+5.93%+4.58%+5.35%+10.18%-9.17%+14.16%+9.70%+2.76%+7.11%-6.80%
Cost of Revenue62.13B77.33B93.32B86.65B90.85B85.67B97.30B86.17B86.63B93.30B101.09B101.01B96.74B128.93B139.25B152.34B135.81B131.29B
Gross Profit21.27B29.22B28.24B23.88B22.91B14.70B9.09B20.52B26.39B24.89B23.42B36.17B27.86B13.31B16.79B8.01B35.94B28.78B
Gross Margin25.50%27.43%23.23%21.61%20.14%14.65%8.54%19.23%23.35%21.06%18.81%26.37%22.36%9.35%10.76%5.00%20.93%17.98%
Operating Expense13.76B11.97B12.01B14.43B14.11B12.75B11.73B12.47B14.77B15.85B16.41B20.76B20.26B24.74B31.60B28.17B24.99B25.17B
Operating Income7.51B17.26B16.24B9.45B8.80B1.95B-2.64B8.04B11.62B9.03B7.01B15.41B7.61B-11.43B-14.81B-20.15B10.95B3.61B
Operating Margin9.01%16.20%13.36%8.55%7.73%1.94%-2.48%7.54%10.28%7.64%5.63%11.23%6.11%-8.04%-9.49%-12.57%6.38%2.25%
EBITDA---------18.87B18.38B25.57B19.92B5.56B2.29B-1.63B31.17B18.31B
EBITDA Margin---------15.96%14.76%18.64%15.99%3.91%1.47%-1.02%18.15%11.44%
Net Income8.74B16.18B14.38B10.92B7.10B1.66B-1.11B6.65B9.43B8.02B7.96B12.26B6.21B-6.58B-16.70B-24.19B8.70B-2.89B
Net Income Margin10.48%15.19%11.83%9.88%6.24%1.65%-1.04%6.24%8.35%6.78%6.39%8.94%4.98%-4.62%-10.70%-15.09%5.07%-1.80%
R&D1.74B2.69B3.32B7.88B7.88B3.53B3.53B4.06B5.62B6.67B7.88B10.70B9.12B11.52B15.43B14.98B3.17B3.36B
R&D as % of Total Revenue2.08%2.53%2.73%7.13%6.93%3.52%3.32%3.80%4.97%5.64%6.33%7.80%7.32%8.10%9.89%9.34%1.84%2.10%
Interest Expense0000000000129.16M153.41M627.81M1.94B2.94B4.99B5.27B5.62B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.10%0.11%0.50%1.36%1.88%3.11%3.07%3.51%

Balance Sheet

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets94.85B111.26B118.27B198.29B185.42B175.50B165.07B170.64B180.91B179.48B184.52B233.35B283.46B298.54B312.59B293.79B284.49B299.87B
Total Liabilities45.70B47.18B42.13B79.29B61.28B51.62B43.22B43.27B45.75B37.44B36.86B74.88B114.71B137.05B164.79B170.76B153.48B172.83B
Total Equity49.15B64.08B76.14B119.00B124.15B123.87B121.85B127.38B135.16B142.05B147.66B158.46B168.75B161.49B147.80B123.02B131.01B127.04B
Cash9.14B15.60B11.62B3.30B17.17B10.35B10.33B10.40B14.95B15.70B11.95B4.49B1.46B3.47B4.66B3.63B1.09B1.43B
Net Debt-----------21.96B76.98B105.12B132.02B141.59B128.96B141.47B

Cash Flow

Currency: KRW2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow10.69B26.57B23.89B12.96B22.90B10.92B11.22B14.34B15.50B20.45B15.54B16.99B4.82B-5.88B-3.20B-7.22B14.03B-4.14B
Investing Cash Flow496.76M-14.78B-20.25B-22.40B-3.47B-4.63B-3.38B-11.95B-11.11B-12.65B-16.14B-44.35B-62.60B-20.39B-20.55B---
Financing Cash Flow-4.20B-5.33B-7.61B1.10B-5.47B-13.10B-7.86B-2.33B140.30M-6.85B-3.13B19.92B54.75B28.27B24.96B---
Capital Expenditure3.47B13.53B19.74B22.09B5.48B4.10B2.87B11.91B10.76B9.67B16.40B47.31B61.66B20.49B6.20B10.78B4.28B6.82B
Free Cash Flow---------10.77B-1.48B-31.00B-57.79B-26.59B-10.43B-18.00B9.75B-10.96B
Dividends Paid1.31B1.31B1.57B2.08B1.80B1.80B512.95M512.95M1.80B2.05B2.05B1.03B1.03B1.10B548.60M--548.60M
FCF to OCF---------52.69%-9.50%-182.44%-1197.86%452.01%325.62%249.20%69.48%264.62%
Dividend Paid to FCF---------19.04%-138.95%-3.31%-1.78%-4.13%-5.26%---5.00%

Earnings

Report DateDec 31, 2005Dec 31, 2006Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 31, 2014Feb 6, 2015May 8, 2015Jul 31, 2015Nov 4, 2015Feb 5, 2016Apr 29, 2016Jul 29, 2016Oct 31, 2016Feb 3, 2017Apr 24, 2017Jul 28, 2017Nov 3, 2017Feb 2, 2018Apr 27, 2018Jul 27, 2018Nov 1, 2018Jan 31, 2019Apr 26, 2019Jul 26, 2019Nov 1, 2019Jan 31, 2020Apr 29, 2020Jul 30, 2020Oct 30, 2020Feb 9, 2021Apr 30, 2021Jul 30, 2021Oct 29, 2021Jan 27, 2022Apr 29, 2022Jul 29, 2022Oct 28, 2022Jan 30, 2023Apr 28, 2023Jul 28, 2023Oct 27, 2023Mar 20, 2024Apr 26, 2024Aug 14, 2024Nov 14, 2024Mar 18, 2025Apr 24, 2025Jul 24, 2025Oct 23, 2025Dec 31, 2025Apr 23, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------------
EPS Actual-3356.8247.32-439.27161.6177.28519.74832.65933.74701.81833.67478.16500.23465.651008.08644.23569.19432.52428.29597.02474.25458.59106.66134.38101.4199.32-27.6212.68-151.00-36.14-30.71137.50157.03542.70398.05602.95571.00235.97341.79403.50444.79475.22164.87403.18305.79440.02328.23426.14589.00617.86676.00483.00624.00252.00-179.90-357.3487.04-777.00-151.98-219.57-897.00-638.00-1289.70-529.59-1230.92-1166.19-1483.19516.19802.8051.99215.04164.09-87.49-397.25-205.84-369.87-985.26
Surprise----------------------------------------------------------------------------
Timing----------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-market--Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap70.11B
Enterprise Value217.68B
Trailing P/E0.00
Forward P/E14.79
PEG Ratio0.00
Price / Sales0.44
Price / Book0.59
Revenue (TTM)159.93B
Gross Profit (TTM)6.95B
EBITDA-7.40B
Profit Margin-14.46%
Operating Margin-13.43%
Return on Equity-16.26%
Return on Assets-4.96%
Shares Outstanding5.49M
Shares Float3.34M
Beta0.61
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
100.00Dec 27, 2024
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
200.00Dec 29, 2020
20191×
190.48Dec 27, 2019
20181×
190.48Dec 27, 2018
20171×
380.95Dec 27, 2017
20161×
380.95Dec 28, 2016
20151×
333.33Dec 29, 2015
20141×
95.24Dec 29, 2014
20131×
95.24Dec 27, 2013
20121×
333.33Dec 27, 2012
20111×
333.33Dec 28, 2011
20101×
380.95Dec 29, 2010
20091×
285.71Dec 29, 2009
20081×
238.10Dec 29, 2008
20011×
47.62Dec 27, 2001

Stock Splits

  • Dec 27, 20191.05:1